Presentation
- Racemic mixture
- Both enantiomers are β1 full agonists, and the (+) enantiomer has some β2 activity
- The (+) enantiomer is an ɑ1 receptor competitive antagonist, whereas the (-) enantiomer is a partial agonist; the net effect is some partial agonist activity
- 250mg in 20ml water + sodium metabisulfite; or
- 250mg in 5ml water + ascorbic acid
Uses
- To augment cardiac output in low cardiac output states e.g. MI, cardiac surgery and cardiogenic shock (0.5 - 20μg/kg/min)
- As an alternative to exercise in stress testing
Pharmacodynamics
- Positive chronotropy, inotropy and myocardia oxygen requirement
- BP normally maintained despite some reduction in SVR
- May precipitate arrhythmias
- Should not be used in those with cardiac outflow obstruction (aortic stenosis, tamponade)
- No effect on splanchnic circulation
Pharmacokinetics
- Only available for IV administration
- VD 0.2L/kg
- Rapidly metabolised by COMT to inactive metabolites
- Metabolites are conjugated and excreted in urine
- Half-life 2mins